- We came away from IHH Healthcare (SGX:Q0F)’s post-result briefing feeling upbeat, due to its timely expansion plans across its key markets. Maintain BUY and SOP-derived MYR7.50 target price, 22% upside, ~1% yield.
- - Read this at SGinvestors.io -
Checklist for each market.
- The acquisition of Timberland Medical Center (TMC) in Kuching has been completed and will be consolidated to the group in March. IHH Healthcare’s key emphasis for Malaysia will be strengthening its local presence, which will keep its nurse retention rate in check.
- - Read this at SGinvestors.io -
- The focus for Turkey is to expand its current regions in Europe (i.e. Bulgaria and Macedonia, Serbia and Netherlands) and to grow its foreign patient visits to Turkey to reduce the impact of hyperinflation.
Recent policy developments in India.
- Read more at SGinvestors.io.
Oong Chun Sung RHB Securities Research | https://www.rhbgroup.com/ 2024-03-05
Read also RHB's most recent report:
2024-05-30 IHH Healthcare - Earnings Supercharged By Strong Operating Stats; BUY.
Price targets by other brokers at IHH Healthcare Target Prices.
Listing of research reports at IHH Healthcare Analyst Reports.
Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividends & Corporate Actions,
IHH Healthcare News Articles
